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O B J E C T I V E S We sought to determine whether gadolinium (Gd)-containing lipid-based nanoparticles
(NPs) targeting the macrophage scavenger receptor-B (CD36) improve cardiac magnetic resonance (CMR)
detection and characterization of human atherosclerosis.
B A C KG ROUND Gd-containing lipid-based NPs targeting macrophages have improved MR detec-
tion of murine atherosclerosis.
METHOD S Gadolinium-containing untargeted NPs, anti-CD36 NPs, and nonspeciﬁc Fc-NPs were
created. Macrophages were incubated with ﬂuorescent targeted and nontargeted NPs to determine uptake
via confocal microscopy and inductively coupled plasma mass spectroscopy (ICP-MS) quantiﬁed Gd uptake.
Human aortic specimens were harvested at autopsy. With a 1.5-T scanner, T1, T2, and PDW 3-dimensional
scans were performed along with post-contrast scans after 24 h incubation. The T1 and cluster analyses were
performed and compared with immunohistopathology.
R E S U L T S The NPs had a mean diameter of 125 nm and 14,900 Gd-ions, and relaxivity was 37
mmol/l1s1 at 1.5-T and 37°C. Confocal microscopy and ICP-MS demonstrated signiﬁcant in vitro
macrophage uptake of targeted NPs, whereas non-targeted NPs had minimal uptake. On T1 imaging,
targeted NPs increased contrast-to-noise ratio (CNR) by 52.5%, which was signiﬁcantly greater than
Fc-NPs (CNR increased 17.2%) and nontargeted NPs (CNR increased 18.7%) (p  0.001). Confocal
ﬂuorescent microscopy showed that NPs target resident macrophages, whereas the untargeted NPs and
Fc-NPs are found diffusely throughout the plaque. Targeted NPs had a greater signal intensity increase
in the ﬁbrous cap compared with non-targeted NPs.
CONC L U S I O N S Macrophage-speciﬁc (CD36) NPs bind human macrophages and improve CMR
detection and characterization of human aortic atherosclerosis. Thus, macrophage-speciﬁc NPs could help
identify high-risk human plaque before the development of an atherothrombotic event. (J Am Coll Cardiol
Img 2009;2:637–47) © 2009 by the American College of Cardiology Foundation
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638he clinical manifestations of atherosclerosis,
namely myocardial infarction and stroke, re-
main the leading cause of morbidity and
mortality in the U.S. (1) and in Western
ociety. Because the majority of acute coronary
yndromes occur from rupture of lesions 50%
tenosed (2,3), identification of high-risk lesions in
ndividuals before rupture can be challenging. De-
ection of these lesions by conventional means of
ssessing atherosclerosis, such as coronary an-
iography, remains limited (4). Atherosclerotic
esions prone to rupture were shown to have a
thin fibrous cap, a large lipid core, and a
large number of inflammatory cells in-
cluding macrophage-derived foam cells
(5,6). Therefore, development of nonin-
vasive imaging agents that target com-
ponents of atherosclerotic plaque might
enable improved detection and charac-
terization of plaque (7).
In an effort to create cardiac magnetic
resonance (CMR) contrast agents that
deliver a large payload of paramagnetic
particles, we developed gadolinium (Gd)-
loaded lipid-based nanoparticles (NPs)
that can be modified to target biological
ligands. As previously described, Gd-
loaded NPs modified with antibodies tar-
geting macrophage scavenger receptor
(MSR)-A (or CD204) not only improved
in vitro CMR detection of macrophages
but also improved ex vivo detection of
murine atherosclerosis and macrophage
density (8). Recently, NPs targeting the
MSR-A were shown to improve in vivo
detection of murine atherosclerosis with a
high correlation between the signal inten-
sity on CMR and the number of macro-
phages in the region of interest (9). CD36,
a class B scavenger receptor, has been
shown to have an important role in oxi-
dized lipoprotein uptake, which might
xplain its increased expression in atherosclerosis.
herefore, we set out to determine whether Gd-
abeled NPs targeting CD36 bind to macrophages
nd improve MR detection and characterization of
uman atherosclerosis.
ystem, Richmond, Virginia. This study was supported in part by NIH/NH
ayad), and the Stanley J. Sarnoff Endowment for Cardiovascular Research, Inc
esource Facility is supported by funding from NIH-NCI shared resource
nstrumentation Grant DBI-9724504.
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Ps formulation. The NPs were made from phospho-
ipids [palmitoyl-oleoyl phosphatidylcholine (POPC),
,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-
-nitro-2-1,3-benzoxadiazol-4-yl (DPPE-NBD), 1,2-
ipalmitoyl-sn-glycero-3-phosphoethanolamine-N-
iotinyl (DPPE-Biotin)], a surfactant (Tween 80),
nd an aliphatic gadolinium complex (Gd-DOTA-
SA, Gateway Chemical, St. Louis, Missouri) as
reviously described (8,10). The POPC and the Gd
omplex were dissolved in a 1:1 chloroform/methanol
olution (5 ml). Evaporation under nitrogen flux
ielded a thin film that was then rehydrated in hot
ater (2 ml, 70°C). This solution was sonicated for 15
in at 70 W at 90% cycle duty while the temperature
as kept at 65°C with a thermostatic bath. After
onication, Tween 80 was added, followed by another
5 min of sonication. Green fluorescent NBD-labeled
ntargeted NPs were obtained by adding 2 mol % of
uorescent phospholipid DPPE-NBD to the formu-
ation, and red fluorescent rhodamine-labeled untar-
eted NPs were obtained by adding 2 mol % of
uorescent phospholipid DPPE-rhodamine to the
ormulation. Biotinylated NPs were prepared by ad-
ition of 0.5 mol % of DPPE-Biotin to the reaction
ixture. Biotinylated rabbit anti-human polyclonal
ntibodies to human CD36 (IgG, Novus Biologicals,
ittleton, Colorado) and biotinylated ChromPure
abbit IgG fragment crystallizable (Fc) region (Jackson
mmunoresearch, West Grove, Pennsylvania) were
sed to make targeted NPs s and Fc-NPs, respec-
ively. Targeted NPs and Fc-NPs were prepared by
dding approximately 1.9  1010 mol/l of biotinyl-
ted NPs dissolved in phosphate buffered solution
PBS) to 9.7  1010 mol/l of streptavidin (Sigma-
ldrich, St. Louis, Missouri), and the vial was shaken
or 30 min. Then 2.3  109 mol/l of biotinylated
nti-CD36 or Fc fragment dissolved in PBS were
dded to the vial and shaken for another 3.5 h. This
nabled the antibody to bind to the NP via a biotin-
treptavidin-biotin bridge. Therefore the solution
ontaining targeted NPs and Fc-NPs had a ratio of 10
arts anti-CD36 or Fc-portion to 5 parts streptavidin
o 1 part NP, ensuring that excess antibody is available
or each particle.
ROI HL71021, NIH/NHLBI HL078667 (to Dr.
Dr. Amirbekian). The MSSM-Microscopy Shared
rant R24 CA095823, and NSF Major ResearchS LBI
F . (to
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N D A C R O N YM S
po apolipoprotein
D204 a class Amacropha
cavenger receptor
D36 a class B macrophag
cavenger receptor
MR cardiac magnetic
esonance
NR contrast-to-noise rati
API 4’,6’-diamidino-2-
henylindole hydrochloride
PPE-NBD 1,2-Dipalmitoy
lycero-3-phosphoethanolam
-7-nitro-2-1,3-benzoxadiazo
d gadolinium
CP-MS inductively couple
lasmamass spectroscopy
SRmacrophage scaveng
eceptor
P nanoparticle
BS phosphate-buffered
olution
DW proton-density-
eighted
PE phycoerythrin
NR signal-to-noise ratio
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639The NPs were characterized by photon correla-
ion spectroscopy performed with a Malvern mul-
iangle dynamic laser light scattering system at
oom temperature, and inductively coupled plasma-
ass spectrometry (ICP-MS) measurements pro-
ided the number of Gd ions/particle (11). The
elaxivity of contrast agents was determined at 37°C
ith a 1.5-T clinical scanner. Two formulations of
Ps were created for this study.
n vitro protocol. Human peripheral blood THP-1
onocytes were isolated with well-established ad-
esion methods (12). The monocytes were activated
y incubation with human recombinant macro-
hage colony-stimulating factor (1 g/ml; Sigma).
he activated monocytes/macrophages were plated
or 1 week in Dulbecco’s modified Eagle medium
ontaining fetal calf serum. The cells were washed
nd further activated by the addition of oxidized
ow-density lipoprotein (5 g/ml, malondialdehyde-
odified low-density lipoprotein), as previously de-
cribed (13). Twenty-four hours after the addition of
alondialdehyde-modified low-density lipoprotein,
he cells were washed with fresh culture medium, and
he NPs were added at a concentration of 1 mmol/l
d. To evaluate the competition between the targeted
nd untargeted particles, cells were incubated as fol-
ows: 1) cells incubated with 1 mmol/l Gd of NBD-
abeled untargeted particles; 2) cells incubated with 1
mol/l Gd rhodamine-labeled targeted particles
CD36); 3) cells incubated with 1 mmol/l Gd NBD-
abeled untargeted particles and 1 mmol/l Gd
hodamine-labeled targeted particles (CD36); and 4)
ontrol cells. All cells were then incubated for 24 h at
7°C. After incubation, the cells were washed (3)
ith PBS and scraped in 0.25 ml of PBS. We then
ransferred 5 l of the cell suspension to a slide and
meared with blood smearing techniques. The cells
ere fixed to the slide (4% paraformaldehyde) and
ashed with PBS. We added 5 l of 4’,6’-diamidino-
-phenylindole hydrochloride (DAPI), the slides were
ounted, and confocal microscopy was performed
fter 24 h. The remaining 0.245 ml of cells were
easured for cell number (bright light counting
hamber) and sent for ICP-MS for Gd quantification.
he resultant Gd concentrations (g/ml) were then
ormalized to the cell numbers present.
x vivo protocol. Aortas with moderate to severe
therosclerotic disease were harvested from subjects
t the time of autopsy. Each piece of aorta was
ivided into 3 equal sections with transverse cuts
cross the arterial lumen, preserving the lumen and
ascular wall. Each section had an approximate
eight of 1 cm. For this experiment, 16 sections of eorta were selected from a total of 6 different
ubjects (4 different aortas yielding 3 sections each,
nd 2 different aortas yielding 2 sections each). The
xperimental design was for 6 aorta sections to be
ncubated with CD36-labeled NPs, 6 aorta sections
o be incubated with untargeted particles, and 4
orta sections to be incubated with unspecific Fc-
articles. Before imaging, the sections of aorta were
emoved from formalin, cleaned, dabbed dry, and
laced in Fomblin solution (perfluoropolyether;
usimont USA Inc., Thorofare, New Jersey) for
MR. Fomblin does not have a residual MR signal
nd does not interfere with the biological tissue
ignal (14). After the initial pre-contrast CMR, the
orta sections were removed, dabbed dry, placed in
ndividual plastic containers with PBS, and the
olution of targeted NPs, untargeted NPs, or Fc-
Ps was added. The plastic containers were covered
nd placed on a shaker for incubation at 4°C for
4 h. After incubation, the aorta sections were
emoved from the solution, cleaned, dabbed dry,
laced in fomblin in their original positions from
he pre-contrast imaging, and were imaged.
x vivo imaging. Pre-contrast and post-contrast im-
ging of the aorta sections was performed with a
iemens Sonata 1.5-T MR system. Sixteen contig-
ous axial images were obtained with T1, T2, and
roton-density weighted (PDW) spin echo se-
uences. This enabled 3-dimensional multicontrast
nalysis of the aortas. The T1 images were obtained
ith a repetition time of 300 ms and an echo time
f 9 ms, T2 images were obtained with a repetition
ime of 2,000 ms and an echo time of 55 ms, and
DW images were obtained with a repetition time
f 2,000 ms and an echo time of 9 ms. The images
ad a slice thickness of 0.5 mm, matrix size of 512
512 pixels, field of view of 12.8  12.8 cm, and
resolution of 0.25  0.25 mm. The T1 sequence
cquisition time was 9 min, T2 acquisition time was
5 min, and PDW sequence acquisition time was
15 min. The receiver gain was automatically
alculated by the CMR system.
onfocal ﬂuorescent microscopy. Confocal laser
canning microscopy was performed at the MSSM-
icroscopy Shared Resource Facility with the ap-
ropriate light sources and filter sets on the control
ortas and aortas incubated with fluorescent CD36-
abeled, untargeted, and unspecific particles. All
rteries were washed and frozen in optical cutting
emperature compound Tissue Tek, Sakura Fine-
ech, Tokyo, Japan). Ten-micron sections were cut
nd mounted on slides and stained with phyco-
rythrin (RPE)-labeled anti-CD68 (excitation
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640avelength: 532 to 561 nm, emission wavelength:
78 to 610 nm) and DAPI (excitation wavelength:
85 to 400 nm, emission wavelength: 450 nm).
nti-CD68 is an antibody directed against lysoso-
al glycoproteins of macrophages (15), whereas
API is known to bind DNA in cellular nuclei
16). The NBD-labeled untargeted NPs had an
xcitation wavelength of 460 nm and emission
avelength of 534 nm. Light microscopy was per-
ormed with and without hematoxylin and eosin
taining to allow histopathological comparison with
orresponding MR images.
mage analysis. Three-dimensional T1 image anal-
sis was performed for each aorta. Sixteen contig-
Confocal Microscopy Demonstrating In Vitro Macrophage
NPs
icroscopy merged images (nitro-2,1,3-benzoxadiazol-4-yl [NBD]
hodamine  red, 4’,6’-diamidino-2-phenylindole hydrochloride
lue) at 100 of activated human monocytes incubated in vitro
l (A), NBD-labeled untargeted nanoparticles (NPs) (B), rhodamine-
s targeting macrophage scavenger receptor-B (CD36) (C), and
BD-labeled untargeted NPs and rhodamine-labeled NPs targeting
nd stained with DAPI. Included with each image in the bottom of
s the Gd concentration (g/ml) normalized to the cell numbers
seen in A, the nuclei of the control cells appear blue, and there was
nt gadolinium (Gd) present as expected. In cells incubated with
NBD-labeled NPs (B), there was trivial green ﬂuorescence seen and
take of Gd as seen on inductively coupled plasma mass spectros-
S). Cells incubated with rhodamine-labeled NPs targeting C36 (C)
ted signiﬁcant red ﬂuorescence corresponding with cellular uptake of
Ps, and ICP-MS also demonstrated signiﬁcant Gd uptake. As seen in
s again signiﬁcant uptake of rhodamine-labeled NPs targeting CD36
ptake of untargeted NBD-labeled NPs. The cellular uptake of Gd as
ICP-MS in D appears similar to the sum of Gd concentrations for Bpous slices were obtained, and analysis was per-
ormed on contiguous slices in which there was no
isruption of the aortic wall (the aorta was present
s a complete circle). Eight regions of interest
panning the intima, media, and adventitia of equal
ize in each aorta for pre-contrast slices were se-
ected, and the corresponding regions of interest
ere selected for the corresponding post-contrast
lice. The mean signal intensity for the 8 regions of
nterest was calculated for each slice along with the
ignal intensity of the noise and the SD of the noise.
he signal-to-noise ratio (SNR) was calculated by
he following equation:
NRmean signal intensity of 8 regions of
interest ⁄ SD of the noise [1]
The mean pre- and post-contrast SNR of each
orta was then determined by taking the average of
he SNR for each slice for pre- and post-contrast
mages, respectively. The change in pre- and post-
ontrast SNR, also known as contrast-to-noise ratio
CNR), was determined by the following equation:
NRPost -Con SNR
Pre-Con SNR/Pre-Con SNR 100 [2]
Composition images were created by merging
ed, green, and blue images in which the T1 image
as converted to a red image, T2 was converted to
green image, and PDW was converted to a blue
mage (14). The histopathological section for each
orta was then compared with the matching com-
osition image. Type IV and V lesions as defined by
tary et al. (17) were identified on histopathological
mages. A dense accumulation of extracellular lipid
hat occupies an extensive but well-defined region
f the intima was used to define a lipid core (17).
he tissue layer between the lipid core and the
ndothelial surface was defined as the fibrous cap
17). Cluster analysis was performed by determin-
ng the T1 pre-contrast and post-contrast SNR for
ach aorta in regions of lipid core and fibrous cap.
tatistical analysis. Comparison of SNR between
re- and post-contrast T1 images was performed
ith paired Student t test analysis. One-way anal-
sis of variance (ANOVA) was performed to com-
are between treatment groups for pre-contrast
NR and post-contrast SNR, respectively. A 2-way
NOVA was performed to compare the CNR of
articular imaging agents to determine superiority
f 1 agent compared with another. Pair-wise com-Figure 1.
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641rror rates. Results are shown as mean  SD.
alues of p  0.05 were considered significant.
umber Crunching System Software (Salt Lake
ity, Utah) was used for all statistical analyses.
E S U L T S
wo formulations of NPs were created for this
tudy. The first formulation was a biotinylated
article with the following characteristics: average
f 14,900 Gd atoms/NP, average diameter of 125.2
m, and an average relaxivity of 37.1 mmol/l1s1.
he second formulation included fluorescent
BD-labeled or rhodamine-labeled biotinylated
article with the following characteristics: average
f 13,800 Gd atoms/NP, average diameter of 125.2
m, and an average relaxivity of 36.0 mmol/l1s1.
Activated human monocytes were incubated for
4 h at 37°C with control media, NBD-labeled
green) untargeted particles (1 mmol/l Gd),
hodamine-labeled (red) anti-CD36 particles (1
mol/l Gd), and a combination of untargeted and
argeted particles (2 mmol/l Gd). Cells were then
repared for confocal microscopy, and the remain-
ng cells were counted and sent to ICP-MS for
Table 1. Pre- and Post-Contrast SNR Values and CNR Values
Variable Pre-Contrast SNR Post-Contrast SNR
Targeted NPs
Aorta 1 20.2 2.9 32.9 7.3
Aorta 2 21.5 0.6 31.8 1.0
Aorta 3 22.7 0.7 33.3 0.5
Aorta 4 17.8 0.4 26.1 0.4
Aorta 15 20.2 0.5 31.2 1.0
Aorta 16 19.0 0.2 28.8 0.1
Average 20.3 1.8 30.9 3.0
Untargeted NPs
Aorta 5 20.4 2.8 24.8 2.8
Aorta 6 23.0 0.6 27.5 1.6
Aorta 7 23.3 0.3 26.9 0.2
Aorta 8 21.2 0.4 24.4 0.6
Aorta 13 21.6 0.3 25.7 0.6
Aorta 14 20.2 0.4 24.1 0.6
Average 21.7 1.3 25.7 1.3
Fc-NPs
Aorta 9 19.9 3.2 23.7 3.2
Aorta 10 20.6 0.4 24.0 0.4
Aorta 11 21.5 0.1 25.0 0.2
Aorta 12 21.2 0.3 24.3 0.5
Average 20.7 1.0 24.2 0.6
1-way ANOVA F-ratio  1.50, p 0.26 F-ratio  15.6, p  0.0
Numbers are expressed as mean SD. Pre- and post-contrast signal-to-noise ratio (
plaque enhancement with gadolinium (Gd)-loaded nanoparticles (NPs) targeting m
ANOVA  analysis of variance.etermination of Gd concentrations with normal-
zation for cell number. As seen in Figure 1, there is
lear uptake of the red rhodamine-labeled anti-
D36 particles by activated lipid-rich human
onocyte-derived macrophages as demonstrated by
oth confocal microscopy and ICP-MS Gd quan-
ification. As shown, there was only limited uptake
f NBD-labeled untargeted particle.
Mean SNR values for pre- and post-contrast T1
mages are presented in Table 1 for each aorta
ection grouped according to whether incubated
ith untargeted, CD36-labeled, or unspecific-Fc
articles. An ANOVA demonstrated no significant
ifference between mean SNR of aorta groups
efore incubation with contrast agents (Table 1).
re- and post-contrast T1 analysis demonstrated
hat targeted NPs increased CNR by 52.5% (20.3
.8 vs. 30.9  3.0, p  0.0001), whereas Fc-
articles increased CNR by 17.2% (20.7  1.0 vs.
4.2  0.6, p  0.0001), and untargeted particles
ncreased CNR by 18.7% (21.7  1.3 vs. 25.7 
.3, p  0.0001). Matched pre- and post-contrast
R images of aortas treated with untargeted,
D36-labeled, and unspecific-Fc particles can be
CNR Paired t Test 2-Way ANOVA
52.5% t  15.3, p  0.0001
18.7% t  14.3, p  0.0001
17.2% t  15.3, p  0.0001 F-ratio  16.1, p  0.0001
values and contrast-to-noise ratio (CNR) values demonstrating the degree of aortic
phage scavenger receptor-B (CD36), Fc-NPs, and untargeted NPs.004
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642een in Figure 2 and illustrate the greater increase in
ignal intensity seen with CD36-labeled particles
elative to the untargeted and unspecific particle
ormulations. The CD36-labeled particles in-
reased CNR significantly when compared with
c-NPs (F-ratio 33.8, p  0.0003) or when com-
ared with the untargeted analogue (F-ratio 45.0, p
0.0001) on 2-way ANOVA. However, the CNR
as not significantly different between aortas
reated with untargeted and unspecific-Fc particles
F-ratio 2.25, p  0.18).
Confocal fluorescence microscopy was performed
n aortas incubated in NBD-labeled untargeted,
D36-labeled, and unspecific-Fc particles. As
hown in Figure 3, red-fluorescent RPE-labeled
nti-CD68, an antibody proven to specifically tar-
et macrophage lysosomes (15), colocalizes with
reen-fluorescent NBD-labeled targeted particles
Figure 2. Pre- and Post-Contrast CMR of Aorta Incubated With N
Comparison of pre- and post-contrast T1 images of aortas treated w
NPs (C and D, respectively), and Fc-NPs (E and F, respectively). Inclu
length. The error bar graph included beside A to F provides a grap
signal-to-noise ratio (brown bars) seen between aorta sections incu
magnetic resonance; other abbreviations as in Figure 1.n the plaque. Because the macrophages are no Songer viable, the colocalization likely represents
inding of targeted NPs to CD36 expressed on the
urface of resident macrophages in the atheroscle-
otic plaque. A corresponding light microscopic
mage reveals that the resident macrophages are
eavily present in a small atheroma with a thin
brous cap. Figure 4 demonstrates confocal micros-
opy of aortic atherosclerotic plaques treated with
ntargeted and unspecific-Fc NPs. It demonstrates
onspecific distribution of these formulations
ithin the aortic plaque. Although there is nonspe-
ific distribution in the atherosclerotic plaque with
D36-labeled particles, there is significant binding
o macrophages as previously shown. The control
orta demonstrates nuclear staining with DAPI and
he staining of macrophages with red-fluorescent
PE-labeled anti-CD68.
Cluster analysis was performed by measuring
35.0
30.0
25.0
20.0
15.0
Fc-NPs Anti-CD36 NPs
Treatment Groups
Gd-loaded NPs targeting CD36 (A and B respectively), untargeted
in the bottom left corner is a scale bar that represents 1 cm in
l representation comparing pre- (orange bars) and post-contrast
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643ipid core or fibrous cap on the basis of comparison
f composition images with histopathological im-
ges stained with hematoxylin and eosin. Image
omparison can be seen in Figure 5. Pre- and
ost-contrast SNR data for fibrous cap and lipid
ore are available in Table 2. A 2-way ANOVA
emonstrated that there was a greater increase in
NR in the fibrous cap compared with the lipid
ore after incubation with CD36-labeled NPs
75.2% vs. 43.7%, respectively, p  0.0003). How-
ver, there was a greater increase of SNR in the
ipid core compared with the fibrous cap after
ncubation with untargeted (24.7% vs. 16.9%, re-
pectively, p  0.0001) and unspecific-Fc particles
22.5% vs. 15.1%, respectively, p  0.01). Aortic
laque incubated with the CD36-labeled particles
eemed to have the greatest increase in signal
ntensity in regions with a large number of resident
acrophages bound by NBD-labeled targeted NPs
Fig. 3).
I S C U S S I O N
he findings of this study demonstrate that Gd-
oaded NPs targeting CD36, a class B scavenger
eceptor, were able to specifically target human
acrophages in vitro as demonstrated by confocal
icroscopy and ICP-MS. Anti-CD36 NPs had
ignificantly greater CNR in cadaveric human aortic
Figure 3. Confocal Microscopy of Atherosclerotic Plaque Demon
Confocal microscopy images of aortic atherosclerotic plaque incuba
(C) phycoerythrin (RPE)-labeled (red) anti-CD68 (macrophage lysoso
beled NPs targeting CD36 (macrophage scavenger receptor) and RP
macrophage content and thin ﬁbrous cap. (E) Corresponding lighttherosclerosis than untargeted and unspecific-Fc sarticles on T1 MR images. Additionally, fluores-
ent confocal microscopy validated that NBD-
abeled, CD36-labeled particles targeted resident
acrophages through colocalization of NBD-
abeled targeted NPs and RPE-labeled anti-CD68.
hereas untargeted and unspecific-Fc particles
ere shown to be nonspecifically distributed
hroughout the atherosclerotic plaque on confocal
icroscopy, the CD36-labeled particles both spe-
ifically targeted the macrophages and were also
onspecifically distributed throughout the plaque.
inally, this study demonstrates that that the
D36-labeled particles had a greater CNR on T1
mages in fibrous plaque, whereas untargeted and
nspecific-Fc particles had a greater CNR on T1
mages in lipid-rich plaque. The greatest increase in
he fibrous plaque with CD36-targeted particles
eemed to occur on periphery of the lipid-rich
laque through binding to macrophages surround-
ng the lipid-rich core.
Targeted imaging of macrophages as a possible
eans of detecting and characterizing atherosclero-
is has been investigated with multiple imaging
odalities (18). The use of CD36-labeled particles
hat specifically target the macrophage scavenger
eceptor to detect atherosclerosis with CMR was
reviously investigated in a murine model of ath-
rosclerosis (8,9). The targeted NPs were shown to
ting Fluorescent Macrophage-Speciﬁc NPs
with (A) NBD-labeled (green) NPs targeting CD36, (B) DAPI (blue),
). The merged image (D) demonstrates colocalization of NDB-la-
beled anti-CD68. The arrow points to an atheroma with high
oscope image. Abbreviations as in Figure 1.stra
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644eceptor types I and II) and resulted in increased
inding and uptake in murine macrophages (8).
ncubation of cells with oxidized low-density li-
oprotein and excess anti-CD204 were both shown
o reduce binding of targeted NPs targeting CD-
04 (8). Additionally, ex vivo imaging of murine
ortic atherosclerosis after incubation with contrast
gents (8) and in vivo aortic plaque MR imaging in
ice injected with contrast agent (9) revealed that
reater enhancement of the atherosclerotic plaque
ccurs with targeted NPs compared with non-
argeted NPs and targeted NPs specifically bound
esident macrophages in the plaque. In the current
tudy, we employed rabbit anti-human antibodies
argeting CD36, a member of the class B scavenger
eceptor family. Both CD36 and MSR-A have
een shown to play a role in the development of
therosclerosis and collectively are responsible for
Confocal Microscopy of Plaque Demonstrating Uptake of NPs
icroscopy merged images (NBD  green, anti-CD68  red, DAPI
100 of atherosclerotic plaque incubated with (A) control (non-
t untargeted NPs), (B) NBD-labeled untargeted NPs, (C) NBD-la-
Ps, (D) and NBD-labeled targeted NPs. The images were of the
que and therefore do not have the auto-ﬂuorescence of the inter-
lamina and media. There was no green ﬂuorescence seen in con-
plaque incubated with non-ﬂuorescent untargeted NPs, whereas
distribution of NBD-labeled untargeted NPs, Fc-NPs, and tar-
can be seen throughout the plaque. An arrow is present in each
dentify resident macrophages. Signiﬁcant colocalization was seen
eled targeted NPs and anti-CD68 (D), whereas signiﬁcant colocal-
s not seen with NBD-labeled untargeted NPs and Fc-NPs (B and
ggests that macrophages are bound by targeted NPs targetinginding and uptake of 75% to 90% of modified sow-density lipoprotein uptake by macrophages
19). Several studies have highlighted the impor-
ance of CD36 for plaque development by demon-
trating significant reduction in the short-term and
ong-term development of atherosclerosis in mice
ith apolipoprotein (Apo)-E knockout and CD36
nockout compared with Apo-E knockout mice
20,21). Additionally, transplantation of stem
ells with CD36 in the double knockout mice
CD36/, Apo-E/) resulted in increased devel-
pment of atherosclerosis (22). However, Moore et
l. (23) found that Apo-E knockout mice lacking
D36 had greater aortic sinus atherosclerosis de-
elopment than Apo-E knockout mice. This study
emonstrates the potential to use molecular MR
maging with NPs targeting CD36 to improve the
etection and characterization of atherosclerotic
laque and might serve as a way to investigate the
ole of CD36 in the progression or regression of
therosclerosis.
Detection of atherosclerosis with CMR has also
een achieved with superparamagnetic iron oxide
articles (SPIOs). Although studies have demon-
trated that SPIOs are taken up by macrophages in
therosclerotic plaque, a recent study investigated
he mechanism of cellular uptake of SPIOs. von
ur Muhlen et al. (24) demonstrated that the
ntegrin Mac-1 is crucial in the uptake of SPIOs,
nd binding/uptake was significantly reduced after
locking Mac-1 with antibodies targeting CD11b.
ltra-small SPIOs have been shown to detect
nflamed carotid atherosclerotic plaques with corre-
ation to macrophage density (25). Additionally,
chogenic imaging agents could be developed to
arget macrophages in atherosclerotic plaque and
nhance plaque detection and characterization. Nu-
lear imaging with positron emission tomography
nd single-photon emission computed tomography
ith imaging agents taken up by macrophages and
oam cells might enable detection and characteriza-
ion of inflamed atherosclerotic plaque (26). Finally,
argeted imaging of macrophages with contrast
gents for computed tomography (27), optical im-
ging, or with multimodal imaging agents (28)
eems very promising.
One limitation of this study is that the imaging was
ot performed on viable aorta due to the ex vivo study
esign in which the aorta was harvested at the time of
utopsy from human subjects. However, our data
emonstrate uptake of targeted and untargeted NPs
y human macrophages in vitro. Additionally, we did
ot determine the role particle diffusion played in ourFigure 4.
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645urface compared with more central or deep macro-
hages. Staining for MSR-A would have provided
dditional information regarding the expression of
ther scavenger receptors on the surface of macro-
hages in the aortic atherosclerotic plaque and enable
omparison with prior studies that investigated scav-
nger receptor expression (29). Another limitation in
he use of particles targeting CD36 is that intravenous
Figure 5. CMR Composition Images Compared With Histopatho
The top image is a composition image created by merging T1 imag
weighted converted to blue. The ﬁgure provides a comparison of t
images stained with hematoxylin. Aorta specimens were incubated
(C). With histopathological comparison, it is possible to determine r
(F), and heavily calciﬁed regions of the plaque (G). The aorta repres
type Vb classiﬁcation, whereas aorta specimens in images A, B, and
Figure 1.
Table 2. Pre- and Post-Contrast SNR Values of the Fibrous Cap
Variable Pre-Con SNR Post-Co
Fibrous cap
Targeted NPs 23.8 0.5 41.7
Untargeted NPs 23.6 0.5 27.6
Fc-NPs 23.9 0.5 27.5
Lipid core
Targeted NPs 16.7 0.8 24.0
Untargeted NPs 17.0 0.5 21.2
Fc-NPs 16.5 0.2 20.2
Pre- and post-contrast SNR values of the ﬁbrous cap and the lipid core in human ao
enables determination, for each contrast agent, of whether CNR is greater in the ﬁ
Abbreviations as in Table 1.dministration of this imaging agent will suffer first
ass effect in the liver by binding to scavenger recep-
ors expressed on the surface of Kuppfer cells (18).
oxicity data for the lipid-based particle platform are
lso lacking; however, studies indicate that liver uptake
f the Gd-labeled particles might limit clinical trans-
ation (30). Similarly, this study only evaluated colo-
alization with macrophages and did not assess bind-
of Aortic Plaque
nverted to red, T2 converted to green, and proton-density-
omposition images with the corresponding light microscope
24 h with targeted NPs (A), untargeted NPs (B and D), and Fc-NPs
ns of the plaque such as the lipid-rich core (E), the ﬁbrous cap
d in D is an example of a heavily calciﬁed aorta consistent with a
end to have numerous type IV and Va lesions. Abbreviations as in
the Lipid Core in Human Aortic Atherosclerosis
R CNR t value p Value
75.2% 24.3 0.0001
16.9% 28.8 0.0001
15.1% 8.9 0.001
43.7% 19.8 0.0001
24.7% 48.1 0.0001
22.5% 20.4 0.0001
therosclerosis incubated with targeted NPs, untargeted NPs, and Fc-NPs. This table
s cap or the lipid core. Numbers are expressed as mean  SD.logy
e co
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646ng of anti-CD36 targeted particles to other cells that
xpress CD36, such as endothelial cells, smooth mus-
le cells, adipocytes, and platelets. An additional lim-
tation of this agent in its current form is the use of
abbit antibodies targeting human CD36. These an-
ibodies will likely result in an immune response
gainst the antibody portion of the imaging agent and
ould therefore limit the use of this agent in tracking
rogression/regression of atherosclerotic plaque. Fu-
ure studies should include isotype-matched antibod-
es to further test specificity of the antibody targeting.
inally, the role of imaging with NPs targeting CD36
emains to be validated for in vivo atherosclerotic
laque detection.
O N C L U S I O N S
d-loaded lipid-based NPs targeting CD36, a class2004;1:48–55. Magn Reson Med 2uman macrophages in vitro, improved signal in-
ensity of ex vivo aortic atherosclerotic plaque, and
ere shown to bind to resident macrophages in
therosclerotic plaque on confocal microscopy. Fi-
ally, the CD36-labeled particles created the largest
ignal intensity in regions of fibrous plaque on the
eriphery of lipid-rich plaque. These data suggest
hat lipid-based NPs targeting CD36 might im-
rove detection and characterization of atheroscle-
otic plaque and determine the degree of plaque
nflammation by assessing macrophage density.
eprint requests and correspondence: Dr. Zahi A. Fayad,
ount Sinai School of Medicine, One Gustave L. Levy Place,
maging Science Laboratories, Box 1234, New York, New
B scavenger receptor, had significant uptake by York 10029. E-mail: zahi.fayad@mssm.edu.1
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